Fisher & Paykel保健面临美国对墨西哥进口品征收关税带来的较高成本, Fisher & Paykel Healthcare faces higher costs from US tariffs on Mexican imports, aiming to keep 65% gross margin.

Fisher & Paykel保健公司预计,由于美国对来自墨西哥的货物征收新的关税,其成本将上升,墨西哥60%的美国产品由美国生产。 Fisher & Paykel Healthcare expects its costs to rise due to new US tariffs on goods from Mexico, where it manufactures 60% of its US-bound products. 尽管成本有可能增加,但该公司的目标是将总利润率目标保持在65%,并计划与供应商和客户合作,以减轻关税影响。 Despite potential cost increases, the company aims to maintain a gross margin target of 65% and plans to work with suppliers and customers to mitigate tariff impacts. 关于关税影响的最新情况将在5月提供,并附有年度结果。 An update on the tariffs' effects will be provided in May with its annual results.